Bypassing Resistance to PI3K Therapy Paves the Way to Novel Anticancer Strategies
Thursday, February 12, 2015 - 16:50
in Health & Medicine
A study led by researchers at The Wistar Institute has shown that targeting both PI3K and the mitochondria within these cancer cells can dramatically improve the effectiveness of targeted therapy and significantly reduce the chances of developing resistance.